Global Decorative Laminates Market (2020 to 2030) - Industry Analysis, Size, Share, Growth, Trends and Forecasts
November 04, 2021 09:03 ET
|
Research and Markets
Dublin, Nov. 04, 2021 (GLOBE NEWSWIRE) -- The "Decorative Laminates Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030" report has been added to...
LimeLight Marketing named 2021 Kansas Woman-Owned Business Professional Service Firm of the Year
November 04, 2021 09:03 ET
|
LimeLight Marketing
PITTSBURG, Kan., Nov. 04, 2021 (GLOBE NEWSWIRE) -- LimeLight Marketing, a digital marketing company that specializes in branding, websites, digital advertising, SEO and social media marketing, has...
Senti Bio to Present Preclinical Advances on Pipeline Candidate SENTI-202 at ASH 2021 Annual Meeting
November 04, 2021 09:02 ET
|
Senti Bio
- Preclinical data demonstrates functionality of SENTI-202 OR/NOT Logic Gated gene circuits for the elimination of AML cells while sparing healthy cells - - SENTI-202 is one of several pipeline...
Editas Medicine to Present Data Demonstrating Progress Towards Transformative Gene Editing Medicines for the Treatment of Hemoglobinopathies and Cancer at the ASH Annual Meeting and Exposition
November 04, 2021 09:02 ET
|
Editas Medicine, Inc.
EDIT-301 preclinical data support differentiated approach to develop a transformative medicine for people living with transfusion-dependent beta thalassemia Preclinical data demonstrating proprietary...
Vincerx Pharma Announces Presentations at the American Society of Hematology Annual Meeting
November 04, 2021 09:01 ET
|
Vincerx Pharma, Inc.
PALO ALTO, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through...
Freeline Therapeutics to Present FLT180a Data at the 2021 ASH Annual Meeting
November 04, 2021 09:01 ET
|
Freeline Therapeutics
LONDON, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage biotechnology company developing transformative...
Autolus Therapeutics to Present New Data at the 63rd ASH Annual Meeting & Exposition
November 04, 2021 09:01 ET
|
Autolus Therapeutics plc
- Demonstrates progress on the Company’s commercial manufacturing process and builds on positive obe-cel clinical data presented at EHA Conference Call and Webcast to be held Tuesday, December 14,...
Fate Therapeutics Announces Eight Presentations at the 2021 ASH Annual Meeting
November 04, 2021 09:01 ET
|
Fate Therapeutics, Inc.
FT596 Oral and FT516 Poster Presentations to Highlight Updated Clinical Data for Relapsed / Refractory Lymphoma on Monday, December 13 Company to Host Virtual Investor Event on Tuesday, December 14 ...
X4 Pharmaceuticals to Have Strong Presence at ASH 2021 with Seven Accepted Abstracts Highlighting New Clinical and Scientific Data; Company Reports Third Quarter Financial Results
November 04, 2021 09:01 ET
|
X4 Pharmaceuticals
Data continue to support mavorixafor’s potential to benefit patients with WHIM syndrome, chronic neutropenia, and Waldenström’s macroglobulinemia Discovery of new prevalent WHIM variant further...
Bio-Path Holdings to Present Clinical Data at the 63rd Annual American Society of Hematology Annual Meeting
November 04, 2021 09:01 ET
|
Bio-Path Holdings, Inc.
HOUSTON, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a...
- September 26, 2024 16:58 ET MSTX, The First Leveraged MicroStrategy ETF in the U.S. Surpasses $300 Million
- September 26, 2024 16:22 ET STMicroelectronics N.V. October 22, 2024 Lead Plaintiff Deadline – STM Stockholders Should Contact Robbins LLP for Information